23andMe stock jumps more than 12% on raised 2023 guidance
The company raised its fiscal 2023 revenue guidance to between $290 million and $300 million, with a net loss in a range of $325 million to $335 million. Shares of 23andMe ended the regular trading day down 0.4%.